Evaluation of the Efficacy of TOPIALYSE Baume Protect+ on Atopic Dermatis

Korábbi kezelés

• Volunteer who received topical corticosteroid or immunosuppressive treatments during the week prior to study entry and during the study.
• Volunteer who received oral corticosteroids during the month prior to study entry.
• Volunteer participating in another study or being in an exclusion period from a previous study.

Más betegség

• Volunteer with a history of allergy or hypersensitivity reaction to a cosmetic or any of the constituents of the test products.
• Presence of dermatosis, skin pathology or systemic disease that, in the opinion of the investigator, may interfere with the evaluation of the study parameters.

Egyéb

• Existence of a systemic or local treatment which, in the opinion of the investigator, may interfere with the evaluation of the parameters studied.

• Volunteer aged between 3 months and 18 years
• Female or male volunteer
• Volunteer with an atopic background and localized and symmetrical right/left signs of mild atopic dermatitis on the face and/or body: On the whole body: 0.1 \< EASI \< 7 \[2\] or
  • Localized - mEASI (cf. Appendix n°1):
  • On the arms: 0.02 \< mEASI \< 1.4
  • On the legs: 0.04 \< mEASI \< 2.8 (0.03 \< mEASI \< 2.1 for children under 8 years old)
  • On the trunk: 0.03 \< mEASI \< 2.1
  • On the head/neck: 0.01 \< mEASI \< 0.7 (0.02 \< mEASI \< 1.4 for children under 8 years old)
• Volunteer agreeing not to use any other skincare product on the face or body for the duration of the study, except for study products,
• Volunteer agreeing not to perform any corticosteroid or immunosuppressive treatment, per os or topical for the duration of the study,
• Volunteer whose parent(s) or legal guardian(s) have given written consent to participate in the study,
• Volunteer related to the social security of a parent or legal guardian in accordance with the French law on interventional research